ARS PHARMACEUTICALS INC (SPRY)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Richard Lowenthal, M.S., MSEL President and Chief Executive Officer | 2025 | $700,000 | $0 | $6,176,110 | $0 | $315,000 | $2,465,290 | $9,656,400 |
| 2024 | $651,000 | $0 | $3,842,080 | $0 | $507,780 | $2,174,135 | $7,174,995 | |
| 2023 | $620,000 | $0 | $0 | $7,293,000 | $260,400 | $1,865,696 | $10,039,096 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Sarina Tanimoto, M.D., M.B.A. Chief Medical Officer | 2025 | $540,000 | $0 | $2,107,247 | $0 | $178,200 | $2,465,024 | $5,290,471 |
| 2024 | $501,698 | $0 | $1,309,800 | $0 | $260,880 | $2,174,395 | $4,246,773 | |
| 2023 | $473,300 | $0 | $0 | $2,320,500 | $132,524 | $1,865,169 | $4,791,493 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Justin Chakma Chief Business Officer | 2025 | $497,000 | $0 | $2,205,409 | $0 | $164,000 | $21,700 | $2,888,109 |